Financhill
Buy
54

ADXN Quote, Financials, Valuation and Earnings

Last price:
$7.06
Seasonality move :
-15.89%
Day range:
$7.16 - $7.55
52-week range:
$6.67 - $27.90
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
13.86x
P/B ratio:
0.61x
Volume:
1.4K
Avg. volume:
8.7K
1-year change:
-36.41%
Market cap:
$8M
Revenue:
$1.8M
EPS (TTM):
-$0.34

Earnings Data

Next earnings date for ADXN
--
Most recent earnings per share
-$2.78
Missed by $2.78
(Sep 30/2024)
Consensus Estimate
--
(Sep 30/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ADXN Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 $236.3K -- -- -- --
12/31/2024 Q4 $177.2K -- -- -- --
09/30/2024 Q3 $130K $62.3K -$2.78 -- --
06/30/2024 Q2 $262.6K $127.5K $10.62 -- --
03/31/2024 Q1 $266.4K $267.2K -$4.12 -- --
12/31/2023 Q4 $717.5K $173.2K -$4.06 -- --
09/30/2023 Q3 $706.5K $371.1K -$4.08 -- --
08/18/2023 Q2 -- $701.9K -$5.34 -- --
03/31/2023 Q1 -- $540.9K -$5.18 -- --
12/31/2022 Q4 -- $615.7K -$4.99 -- --
09/30/2022 Q3 $232.6K $423.9K -$11.18 -- --
08/18/2022 Q2 -- $190K -$23.63 -- --
05/05/2022 Q1 -- $256.8K -$19.49 -- --
03/10/2022 Q4 -- $431.2K -$16.92 -- --
11/01/2021 Q3 -- $742.9K -$14.38 -- --
08/05/2021 Q2 -- $1.1M -$18.45 -- --
05/03/2021 Q1 -- $933.4K -$10.61 -- --
03/08/2021 Q4 -- $2M -$10.62 -- --
11/02/2020 Q3 -- $29.7K -$15.66 -- --
08/12/2020 Q2 -- $893.2K -$14.94 -- --
03/31/2020 Q1 -- $934.3K -$19.84 -- --
12/31/2019 Q4 -- $1.1M -$16.97 -- --
09/30/2019 Q3 -- $509.9K -$17.05 -- --
06/30/2019 Q2 -- $518K -$20.34 -- --
03/31/2019 Q1 -- $703.4K -$14.45 -- --

Addex Therapeutics Earnings Questions

  • How Much did Addex Therapeutics Generate in Revenue Last Quarter?

    Addex Therapeutics reported $62.3K worth of top line sales in its most recent quarter.

  • Did Addex Therapeutics Beat Earnings Last Quarter?

    Addex Therapeutics announced earnings per share of -$2.78 which represents a miss of analyst forecast a -- per share.

  • Is Addex Therapeutics Profitable?

    Addex Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Addex Therapeutics EPS Next Year?

    Addex Therapeutics's earnings are forecast to grow from -$18.71 per share to -- per share next year representing an increase of --.

  • When is Addex Therapeutics's Earnings Date?

    Currently, Addex Therapeutics has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on June 25, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Rivian a Good Stock a Buy?
Is Rivian a Good Stock a Buy?

Rivian Automotive (RIVN) had an initial IPO of close to…

Will Chevron Acquire Hess?
Will Chevron Acquire Hess?

Long-time Buffett favorite in the energy sector Chevron (NYSE:CVX) is…

Why Did Progressive Stock Go Down?
Why Did Progressive Stock Go Down?

Shares of insurance giant Progressive (NYSE:PGR) have fallen considerably over…

Stock Ideas

Buy
58
Is AAPL Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 37x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Sell
47
RGC alert for Mar 26

Regencell Bioscience Holdings [RGC] is up 4.9% over the past day.

Sell
39
W alert for Mar 26

Wayfair [W] is up 2.01% over the past day.

Sell
46
TSLA alert for Mar 26

Tesla [TSLA] is up 3.5% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock